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Conclusion: Thus, we have found that metformin significantly
increases the rate of catabolism of adenosine, and this in turn
reduces the inhibitory effect on the tumor microenvironment
cytotoxic cells. Therefore, our data for the first time provide novel
evidence for a mechanism that the anticancer activities of met-
formin are due to adenosine metabolism regulation.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.090
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Background: Human epidermal growth factor receptor-2
(HER2/nue) is overexpressed in breast cancer. It has been shown
that HER2-targeted therapies have radically changed the outcome
of HER2-positive breast cancer patients. The aim of this study was
to develop the technique for preparation of recombinant anti-
HER2/neu antibody from plants and to provide with the basic
characteristics of the HER2/neu oncoprotein.
Materials and Methods: We have designed and synthesized
viral vectors to transform Agrobacterium tumifaciens affinity,
ion exchange and gel filtration chromatography were used to pur-
ify the antibody. The quality of the substance was confirmed by
SDS–PAGE and ELISA. The biological activity was tested by
immunofluorescent analysis.
Results: Antibodies were purified by affinity and ion
exchange chromatography from the Agrobacterium tumifaciens
leaves extracts. Gel filtration chromatography was used for
final purification of the protein. Immunocytochemical staining
was performed to test the functional activity of the plant-
made antibodies. Here we also show that plant-made antibod-
ies bind to HER2/neu receptors on the surface of human
SK-BR-3 breast cancer cells as effectively as the diagnostic
antibody A0485 (DAKO, Denmark). Flow cytometry analysis
was used for quantitative estimation of recombinant anti-
HER2/neu antibodies: from 75.7% to 98.3% cells bound the
plant-made antibodies. The same data were obtained with
trastuzumab.
Conclusion: Based on the data obtained, we conclude that
plant-made antibodies inhibit HER2/neu+ breast cancer cell pro-
liferation. Additional experiments are required to prove that tras-
tuzumab and plant-made antibodies share full identity in their
biological activity.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.091
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Papillary thyroid cancer (PTC) is the most common malig-
nancy of the endocrine system. The most frequent genetic alter-
ation in PTC is the BRAF V600E mutation, which affects the
activation of several intracellular signaling pathways. As a result,
changes in the expression levels of cell membrane integrin
receptors and their ligands – extracellular matrix proteins – osteo-
pontin (OPN) and thrombospondin -1 (TSP1) are observed. This
process increases the metastatic potential of tumor cells. Thus,
integrin receptors and their ligands are potential biomarkers of
an aggressive PTC phenotype.
The aim of our study was to compare the gene expression pro-
file of integrins ITGA2, ITGA3, ITGAV, ITGA6, ITGA9, ITGB1, ITGB3
and their ligands OPNa, OPNb, and TSP1 in PTC with different
BRAF V600E mutation status.
Intraoperative thyroid tissue samples from 41 patients diag-
nosed with PTC (n = 26), diffuse nodular nontoxic goiter (n = 10)
and follicular adenoma (n = 5) were analyzed to evaluate the
expression levels of the investigated genes by real time RT-PCR.
Fluorescent immunohistochemistry (IHC) was used to confirm
the PCR results and to estimate the amount of protein products.
For IHC, frozen and paraffin sections were used. The BRAF
V600E mutation was determined using allele-specific amplifica-
tion. Nonparametric criteria (Kruskal Wallis, Wilcoxon and
Mann–Whitney tests) were used to evaluate group differences. P
values of less than 0.05 were considered statistically significant.
The BRAF V600E mutation was observed in 12 PTC samples,
which corresponds to 46% of PTC cases. An increase of gene
expression level of ITGA3 (2.9-fold, p = 0.014), ITGAV (1.9-fold,
p = 0.038), ITGB1 (1.7-fold, p = 0.026), OPNb (2.5-fold, p = 0.0001)
and TSP1 (3.2-fold, p = 0.017) was identified in the PTC tissues,
and a high gene expression level of OPNb (5.9-fold, p = 0.003)
and TSP1 (12.1-fold, p = 0.005) was identified in the tissue samples
of lymph node metastases compared to the conventionally
normal tissue.
In the samples with advanced cancer (T3, T4, TNM) the
expression levels of ITGA3, ITGA6 and ITGA9 were higher com-
pared to the T1 samples. MRNA levels of ITGA3 and ITGAV were
significantly higher in the PTC BRAF V600E positive samples than
in the BRAF V600E negative samples.
Elevated levels of OPNa (11.4-fold, p = 0.0112), OPNb (10.2-fold,
p = 0.0216) and TSP1 (33.5-fold, p = 0.0005) genes were observed in
the follicular adenoma samples compared to the PTC tissues. For
ITGA2 and ITGB3 there was a significant increase of expression in
the PTC tissues compared to the benign thyroid tumors (8.9-fold,
p = 0.019 and 38.4-fold, p = 0.014, respectively).
We also studied the distribution and localization of integrins
ITGA2 and ITGB3 in the thyroid tissues by IHC. In normal thyroid
tissues ITGA2 and ITGB3 were located mainly in the follicular
membrane. In the PTC tissue samples another location of the
integrins was registered: ITGA2 was located mainly in the
papillary structures, whereas ITGB3 was seen both at the basal
and apical surfaces of thyrocytes. Follicular adenomawas charac-
terized by a uniform distribution of both ITGA2 and ITGB3.
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The observed changes in the expression levels of the studied
genes indicate their potential role in tumor progression and a
possible impact on their expression of the mutant product of
the BRAF gene. Integrins and their ligands, OPN and TSP1, could
be considered potential markers in determining the prognosis
and treatment of PTC.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.092
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Preoperative differential diagnosis of benign thyroid nodules
and thyroid cancer is an important issue of endocrinology. Preop-
erative identification of a tumor type allows a surgeon to deter-
mine an adequate surgical treatment and reduce complications.
The cytological analysis of samples obtained by the fine-needle
aspiration biopsy is limited in sensitivity and specificity and the
core biopsy is not safe to be used in patients with thyroid nodes
smaller than 2 cm. The most promising area in the preoperative
diagnosis of malignant tumors is molecular biomarkers, which
can be used to determine the surgical treatment and indications
for the target therapy. BRAF V600E is the most frequent genetic
alteration in thyroid cancer. It activates the MAP-kinase pathway
which causes changes in expression levels of extracellular matrix
proteins and some of their receptors. Changes in the expression
of integrin receptors and their ligands, such as osteopontin and
thrombospondin-1, contribute to tumor cell proliferation and
migration. The C-Jun pathway is also very important in pathogen-
esis of thyroid cancer. Changes in its activity can affect the
expression of GSTP enzyme which participates in hormone
metabolism. Altered MiRNA expression has been observed in a
variety of cancer states allowing their potential use as cancer
biomarkers.
The aim of this study was to evaluate integrins, angiogenic
factors, GSTP and MiRNAs as potential biomarkers for the diagno-
sis and prognosis of thyroid cancer.
112 samples of papillary thyroid cancer (PTC) and 120 samples
of benign nodular neoplasms were analyzed. The expression
levels of the studied genes were determined by RT-PCR. The
results were confirmed by immunohistochemical analysis. The
BRAF V600E mutation was determined by allele-specific real-
time PCR. The results showed that GSTP can be used for clinical
settings as a cancer-specific marker for thyroid neoplasms with
83–88% sensitivity, 70–80% specificity and 76–84% diagnostic
accuracy. Higher expression levels of integrins a2, a5, av, a9, b1,
b3 and IL-8, angiogenin, and VEGF were observed in malignant
tumors in comparison with the normal thyroid tissue (p < 0.05).
The BRAF V600E mutation was detected in 70% of all PTC cases.
In the BRAF V600E positive PTC samples the levels of ITGA3 and
ITGAV expression were higher than in the BRAF V600E negative
ones (p < 0.05). The expression of miRNA 21, 221, 222, 155 was
significantly increased in the cancer samples compared to the
benign neoplasms. Thus, the studied molecular markers could
be used for preoperative diagnosis of thyroid neoplasms and the
treatment approach.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.093
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Background: Metabolic acidosis is a feature of many extreme
physiological and pathological conditions; it is characterized by
mitochondria dysfunction, increased membrane permeability
and changes in the conformation of the protein molecules in vio-
lation of their enzymatic properties. In acidosis, intracellular pH
shifts to the acidic side, which gives antitumor effect to the cyto-
static agent the tumor was resistant to. It is known that the per-
itumoral zone is a buffer between the tumor and healthy tissue,
so abnormalities in the tumor microenvironment changing con-
ditions in peritumoral area will likely affect the tumor status
and its response to antitumor therapy. The degree of tissue meta-
bolic acidosis in affected area can be increased by blocking the
activity of mitochondria and their contribution to the energy sup-
ply of the cells and using pharmacological agents that cause sep-
aration of processes of cellular respiration and oxidative
phosphorylation. Thus, the conditions of energy blockade can
be created in the perifocal area of the tumor. The aim was to
study the possibility of increasing the influence of antitumor
cytostatic by modeling damages of the energy forming processes
in the peritumoral area of the tumor through the creation of
metabolic acidosis.
Material and methods: Experimental work fragment was car-
ried out in 60 rats with sarcoma 45 (S45) transplanted under the
back skin. Cyclophosphamide (C) was administered intraperi-
toneally twice at a dose of 5 mg/kg. On the tumor peritumoral
area perimeter (in 4 points) 0.25 ml of a 1% solution of ATP or
1% solution of diphenhydramine (D) were administered. Clinical
studies were performed on 60 patients diagnosedwith breast can-
cer. These patients underwent two cycles of CMFA chemotherapy:
C 800 mg/m2, methotrexate 30 mg/m2, fluorouracil 2000 mg/m2,
doxorubicin 80 mg/m[b]; on a background of peritumoral injec-
tion of 0.5 ml of a 1% solution of ATP or 1% solution of D.
Results: Modelling of metabolic acidosis in peritumoral area
was shown to result in dissociation of respiration processes and
oxidative phosphorylation of cells (suppression of SDH activity
by ATP by 62% and D by 57.9% and an increase in activity of aGFDG
by ATP and D by 154.7%) the ratio of SDH and aGFDG less than 1.
Morphologic study of S45 showed the development of wide
connective border in the subcapsular zone with the inclusion of
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